Drawing for CLINICAL UNIVERSE

USPTO serial 79308977

CLINICAL UNIVERSE

Reviewed by CopyMark Law Group

Reg. 6776803Status 700Registered
Filing date
Status date
Registration date
Jul 5, 2022
Examiner
MAHMOUDI, MARIAM AZIZ
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CLINICAL UNIVERSE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Craig Fieschko

Craig Fieschko DeWitt LLP2 E. Mifflin St. #600Madison, WI 53703UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Downloadable and recorded computer software for use in recording, storing, analyzing and displaying medical and pathology test results; downloadable and recorded computer software for use in receiving test orders from clinical, medical, veterinary and management information systems, and creating and transmitting test orders to medical and pathology testing devices; downloadable and recorded communication software for use in receiving the output of medical and pathology testing devices; downloadable and recorded computer software for use in converting the output of medical and pathology testing devices to industry standard formats; downloadable and recorded communication software for use in transmission of the output of medical and pathology testing devices to clinical, medical, veterinary and management information systems; downloadable and recorded communication software for use in remote monitoring of the output of medical and pathology testing devices; downloadable and recorded computer software for use in notifying individual personnel of specific test results, events or circumstances relating to medical and pathology test results; downloadable and recorded computer software for assembling, managing and communicating data arising from the use of point of care medical and pathology testing devicesACTIVE—
042Advisory services relating to computer software; technological advisory services relating to the computer and scientific technology used in point of care pathology testing devices; developing and design of computer software; developing of new technology for others in the field of communication interfaces to medical devices; technological advisory services relating to the computer and scientific technology used in communication interfaces to medical devices; installation and maintenance of computer software; updating of computer software; advisory services relating to computer systems analysis; software as a service featuring software for use in recording, storing, analyzing, and displaying medical and pathology test results; software as a service featuring software for use in receiving the output of medical and pathology testing devices; software as a service featuring software for use in converting the output of medical and pathology testing devices to industry standard formats; software as a service featuring software for use in providing alerts of specific test results, events or circumstances relating to medical and pathology test results; software as a service featuring software for use in remote monitoring of the output of medical and pathology testing devices; software as a service featuring software for use in transmission of the output of medical and pathology testing devices to clinical, medical, veterinary and management information systems; software as a service featuring software for assembling, managing and communicating data arising from the use of point of care pathology testing devicesACTIVE—
044Medical diagnostic testing and analysis services for medical diagnosis and treatment purposes; medical diagnostic services, namely, remote monitoring of medical diagnostic test results for medical diagnosis and treatment purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 27, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 7, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 13, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 13, 2022FIMPFINAL DISPOSITION PROCESSED—
Oct 5, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 5, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 5, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 3, 2022GPNXNOTIFICATION PROCESSED BY IB—
Apr 19, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 19, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 13, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 13, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 30, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 14, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 14, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Mar 14, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 14, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 14, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 4, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Mar 4, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 4, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 4, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 4, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 4, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 6, 2021RFNTREFUSAL PROCESSED BY IB—
Nov 17, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 17, 2021RFRRREFUSAL PROCESSED BY MPU—
Oct 16, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 15, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 14, 2021DOCKASSIGNED TO EXAMINER—
Apr 20, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 16, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 15, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance